A suite of new studies suggest drugs such as Ozempic and Zepbound might slow tumor progression and improve survival, but more research is needed to confirm the findings.
Source link
About The Author
A suite of new studies links popular weight-loss and diabetes drugs to lower cancer risks and better outcomes for those with the disease, though researchers say more research is needed